JT
REGN icon

Jump Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Jump Trading’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,436
Closed -$501K – 482
2016
Q2 		$501K Buy
+1,436
New +$553K 0.02% 413
2015
Q1 		– Sell
-1,783
Closed -$731K – 875
2014
Q4 		$731K Buy
+1,783
New +$701K 0.02% 377

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Jump Trading's REGN Position: Q3 2016 in Review

Jump Trading sold out of Regeneron Pharmaceuticals (REGN) in Q3 2016, closing a stake of 1,436 shares — an estimated $501K sold.

Jump Trading first reported a position in REGN in Q4 2014 and held it in 2 quarters. The position peaked at $731K in Q4 2014. 555 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

  • Jump Trading reported no remaining Regeneron Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Jump Trading sold 1,436 Regeneron Pharmaceuticals shares in Q3 2016, an estimated $501K.
  • Jump Trading first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Jump Trading's Regeneron Pharmaceuticals position peaked at $731K in Q4 2014.
  • 555 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Jump Trading's 13F filing for Q3 2016, filed 14 Nov 2016.